We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sponsors Must Consider Risks With Live Case Presentations, FDA Says
Sponsors Must Consider Risks With Live Case Presentations, FDA Says
May 8, 2014
The FDA is creating tough new standards for clinical trials that use live case presentations, requiring that devicemakers discuss all potential risks and benefits in their investigational plans.